Unsedated transnasal esophagoscopy: a sensitive and safe outpatient screening tool
Article Category: Brief communication (Original)
Published Online: Jan 31, 2017
Page range: 491 - 494
DOI: https://doi.org/10.5372/1905-7415.0904.418
Keywords
© 2015 Premsuda Sombuntham, Worawat Rawangban
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Background
Unsedated transnasal esophagoscopy is an emerging screening tool for head and neck cancer evaluation. It has been popular because of its acceptance and cost-effectiveness in an office setting.
Objectives
To evaluate indications, outcomes, and complications of unsedated transnasal esophagoscopy among patients at our hospital.
Methods
A retrospective, descriptive review of data recorded from patients who underwent transnasal esophagoscopy (TNE) without sedation at ENT department. Demographic data, indication, and clinical record were collected.
Results
We retrospectively reviewed the records of 58 patients. Their mean age was 57.4 years (range 18-84 years), and the cohort comprised 43 men and 15 women. Indications for TNE (total 72) were second primary cancer surveillance 34/72 (47%), swallowing problem 27/72 (38%), head and neck clinical staging 8/72 (11%), and voice problem 3/72 (4%). Tissue biopsy positive for esophageal cancer was found in 5/58 patients (9%). Two patients (3%) had major complications.
Conclusions
Transnasal esophagoscopy is a safe and practical screening tool for detecting esophageal cancer. This procedure allows otolaryngologists early detection of cancer in an office setting.